You searched for "Diabetic"
Efficacy of intravitreal dexamethasone implant in patients with persistent macular oedema
1 December 2014
| Sofia Rokerya
|
EYE - Vitreo-Retinal
Chronic cystoid macular oedema (CME) can develop secondary to various pathologies such as diabetic maculopathy, retinal vein occlusion and uveitis. It can cause significant visual impairment and macular damage. The therapeutic effect of corticosteroids in CME is through one or...
Incidence and risk factors of ocular hypertension following PPV and SOI
1 December 2018
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this prospective, interventional study the authors evaluated the risk factors for elevated intraocular pressure (IOP) after pars plana vitrectomy (PPV) with silicone oil injection (SOI). This study included 254 eyes of 254 patients, with a mean age of 55.33...
“Robot performs cataract surgery on patient!”
1 June 2018
|
EYE - Cataract, EYE - Refractive
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are scientific reality and which are ‘fake news’. Headline: “Robot performs cataract surgery on patient!” Twenty-five years ago when Eye News launched, a news headline such...
Worshipful Company of Spectacle Makers awards silver Fincham medal to Professor Shahina Pardhan
The Worshipful Company of Spectacle Makers has demonstrated its continuing support for research by awarding its prestigious Silver Medal to Professor Shahina Pardhan, the UK’s first female Professor of Optometry, and by renewing its commitment to further medal awards for academic and clinical achievement.Moorfields implementing a non-medical intravitreal injection service
28 March 2025
This highly sought after intravitreal injection course has had a national and global impact by enabling numerous institutions to establish their own non-medical delivered IVT injection services. With an increasing demand in treatment for people with eye conditions such as...
Moorfields: Implementing a non-medical intravitreal injection service
4 July 2025
This highly sought after intravitreal injection course has had a national and global impact by enabling numerous institutions to establish their own non-medical delivered IVT injection services. With an increasing demand in treatment for people with eye conditions such as...
Mainline Instruments Announces NHS Approval for iCare DRSplus Fundus Imaging System
Mainline Instruments is excited to share that the iCare DRSPlus Confocal Fundus Imaging System has received official approval from the NHS for use in the Diabetic Eye Screening (DES) Programme. This recognition follows a rigorous evaluation process, confirming that the...Implementing technology to improve global eye health
3 October 2024
| Elliott Taylor, Covadonga Bascaran, Islay Mactaggart, Farhana Rehman-Furs, Andrew Bastawrous, Marcia Zondervan
|
EYE - Vitreo-Retinal
Technological innovation is providing new solutions to transform global eye health [1–5]. In particular, research towards the development of artificial intelligence (AI) tools in ophthalmology has gained pace in recent years. However, there has been little research relating to its...
Across the globe and into the world of international eye grading
4 October 2023
| Rahila Bashir
|
EYE - Imaging
Decades have passed and the influence of analysing fundus images by grading consultants and retinal image specialists has grown worldwide. Their job is to specialise in assessing hundreds of diagnosed eye disease disorders and to read thousands of eye images,...
“I can see fine. Why do I need my eyes tested?”
2 December 2019
| Janet Pooley
|
EYE - General
Are routine eye examinations really necessary? The author asks whether frequent appointments in low-risk patients with normal results are actually cost-effective. It’s recommended that most people should get their eyes tested every two years.” [1] This message is widely publicised...
Strategies for managing neovascular AMD and DMO in routine clinical care
1 October 2015
| Rod McNeil
|
EYE - Vitreo-Retinal
Treatment practice in the management of neovascular age-related macular degeneration (AMD) and diabetic macular oedema (DMO) illustrate increasing adoption of patient-tailored treatment approaches based on initial diagnosis and regular monitoring of imaging and visual outcomes in routine clinical care. The...